| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.936 | 0.003 | 0.936 | Amyloid beta aggregation inhibitor | 0.599 0.008 CID_154699691 | ||
| 0.817 | 0.015 | 0.818 | Apoptosis agonist | 0.818 0.015 CID_154699691 | CID_154699691 | |
| 0.763 | 0.004 | 0.783 | Free radical scavenger | 0.783 0.004 CID_154699691 | CID_154699691 | |
| 0.761 | 0.003 | 0.761 | Breast cancer-resistant protein inhibitor | 0.154 0.022 CID_154699691 | ||
| 0.717 | 0.005 | 0.816 | Antioxidant | 0.816 0.004 CID_154699691 | CID_154699691 | |
| 0.709 | 0.007 | 0.709 | 12-Lipoxygenase inhibitor | |||
| 0.697 | 0.003 | 0.697 | Interleukin 1b antagonist | 0.45 0.005 CID_154699691 | ||
| 0.689 | 0.004 | 0.689 | Interleukin 1 antagonist | 0.36 0.008 CID_154699691 | ||
| 0.676 | 0.005 | 0.676 | Superoxide dismutase inhibitor | |||
| 0.68 | 0.023 | 0.885 | Transcription factor NF kappa B inhibitor | 0.885 0.007 CID_154699691 | CID_154699691 | |
| 0.657 | 0.007 | 0.657 | Lipoxygenase inhibitor | |||
| 0.637 | 0.008 | 0.637 | Caspase 3 stimulant | 0.526 0.017 CID_154699691 | ||
| 0.631 | 0.004 | 0.631 | P-glycoprotein inhibitor | 0.457 0.011 CID_154699691 | ||
| 0.618 | 0.005 | 0.841 | Monophenol monooxygenase inhibitor | 0.841 0.003 CID_154699691 | CID_154699691 | |
| 0.589 | 0.005 | 0.589 | MAO inhibitor | |||
| 0.587 | 0.004 | 0.79 | Amylase inhibitor | 0.79 0.002 CID_154699691 | CID_154699691 | |
| 0.595 | 0.012 | 0.595 | Interleukin antagonist | 0.355 0.038 CID_154699691 | ||
| 0.575 | 0.01 | 0.608 | Antiamyloidogenic | 0.608 0.008 CID_154699691 | CID_154699691 | |
| 0.549 | 0.005 | 0.549 | Transcription factor STAT inhibitor | 0.271 0.073 CID_154699691 | ||
| 0.548 | 0.004 | 0.548 | 5-Lipoxygenase inhibitor | |||
| 0.545 | 0.005 | 0.545 | MAO B inhibitor | |||
| 0.589 | 0.057 | 0.832 | Antiinflammatory | 0.832 0.011 CID_154699691 | CID_154699691 | |
| 0.535 | 0.005 | 0.535 | Transcription factor STAT3 inhibitor | 0.308 0.05 CID_154699691 | ||
| 0.532 | 0.007 | 0.532 | Pyruvate kinase inhibitor | 0.198 0.082 CID_154699691 | ||
| 0.518 | 0.006 | 0.66 | Melanin inhibitor | 0.66 0.003 CID_154699691 | CID_154699691 | |
| 0.511 | 0.005 | 0.511 | Chelator | 0.143 0.038 CID_154699691 | ||
| 0.504 | 0.015 | 0.633 | Nitric oxide antagonist | 0.633 0.008 CID_154699691 | CID_154699691 | |
| 0.536 | 0.048 | 0.584 | Caspase 9 stimulant | 0.584 0.038 CID_154699691 | CID_154699691 | |
| 0.509 | 0.026 | 0.642 | Histamine release inhibitor | 0.642 0.007 CID_154699691 | CID_154699691 | |
| 0.503 | 0.02 | 0.612 | Apoptosis antagonist | 0.612 0.009 CID_154699691 | CID_154699691 | |
| 0.502 | 0.028 | 0.502 | Streptokinase A inhibitor | |||
| 0.47 | 0.004 | 0.772 | Beta glucuronidase inhibitor | 0.772 0.002 CID_154699691 | CID_154699691 | |
| 0.484 | 0.03 | 0.484 | GABA C receptor rho-3 antagonist | |||
| 0.448 | 0.004 | 0.448 | HIV-1 integrase (3'-Processing) inhibitor | 0.163 0.012 CID_154699691 | ||
| 0.447 | 0.041 | 0.447 | Thioredoxin glutathione reductase inhibitor | |||
| 0.401 | 0.003 | 0.401 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.111 0.032 CID_154699691 | ||
| 0.402 | 0.005 | 0.402 | Cystathionine beta-synthase inhibitor | 0.298 0.01 CID_154699691 | ||
| 0.403 | 0.012 | 0.403 | Tubulin antagonist | 0.104 0.097 CID_154699691 | ||
| 0.415 | 0.027 | 0.415 | Hypoxia-inducible factor 1 alpha inhibitor | 0.386 0.034 CID_154699691 | ||
| 0.39 | 0.004 | 0.39 | HIV-1 integrase (Strand Transfer) inhibitor | 0.149 0.013 CID_154699691 | ||
| 0.42 | 0.034 | 0.42 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.389 | 0.005 | 0.389 | Interleukin 4 antagonist | 0.239 0.015 CID_154699691 | ||
| 0.392 | 0.009 | 0.392 | MAO A inhibitor | |||
| 0.387 | 0.006 | 0.387 | Heat shock protein 90 alpha antagonist | |||
| 0.385 | 0.004 | 0.385 | Succinate dehydrogenase inhibitor | 0.17 0.081 CID_154699691 | ||
| 0.395 | 0.015 | 0.395 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.427 | 0.047 | 0.427 | Vasodilator, peripheral | 0.407 0.053 CID_154699691 | ||
| 0.39 | 0.011 | 0.39 | Phospholipase C inhibitor | 0.224 0.032 CID_154699691 | ||
| 0.386 | 0.007 | 0.386 | Tumour necrosis factor antagonist | 0.152 0.098 CID_154699691 | ||
| 0.409 | 0.032 | 0.649 | Vasodilator, coronary | 0.649 0.005 CID_154699691 | CID_154699691 | |
| 0.384 | 0.01 | 0.384 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.384 | 0.01 | 0.435 | Lipid peroxidase inhibitor | 0.435 0.008 CID_154699691 | CID_154699691 | |
| 0.389 | 0.023 | 0.845 | Angiogenesis stimulant | 0.845 0.003 CID_154699691 | CID_154699691 | |
| 0.429 | 0.064 | 0.69 | Antibacterial | 0.69 0.009 CID_154699691 | CID_154699691 | |
| 0.366 | 0.011 | 0.366 | Protein-tyrosine phosphatase inhibitor | 0.241 0.033 CID_154699691 | ||
| 0.402 | 0.049 | 0.63 | Cholesterol antagonist | 0.63 0.015 CID_154699691 | CID_154699691 | |
| 0.363 | 0.013 | 0.507 | Interferon gamma antagonist | 0.507 0.006 CID_154699691 | CID_154699691 | |
| 0.357 | 0.009 | 0.357 | Cyclooxygenase 1 inhibitor | 0.193 0.037 CID_154699691 | ||
| 0.441 | 0.094 | 0.441 | Transcription factor inhibitor | |||
| 0.352 | 0.005 | 0.564 | Xanthine oxidase inhibitor | 0.564 0.003 CID_154699691 | CID_154699691 | |
| 0.412 | 0.07 | 0.412 | 15-Lipoxygenase inhibitor | |||
| 0.365 | 0.026 | 0.365 | Peroxidase inhibitor | |||
| 0.371 | 0.033 | 0.735 | Hypoglycemic | 0.735 0.005 CID_154699691 | CID_154699691 | |
| 0.398 | 0.068 | 0.398 | Prostaglandin dehydrogenase inhibitor | |||
| 0.431 | 0.102 | 0.68 | Alpha-glucosidase inhibitor | 0.68 0.037 CID_154699691 | CID_154699691 | |
| 0.338 | 0.016 | 0.461 | DNA methyltransferase I inhibitor | 0.461 0.005 CID_154699691 | CID_154699691 | |
| 0.326 | 0.003 | 0.326 | Papain-like protease (SARS coronavirus) inhibitor | 0.151 0.033 CID_154699691 | ||
| 0.352 | 0.033 | 0.352 | Insulysin inhibitor | |||
| 0.328 | 0.009 | 0.328 | Protein-tyrosine phosphatase 1B inhibitor | 0.235 0.02 CID_154699691 | ||
| 0.35 | 0.032 | 0.35 | Antimitotic | 0.188 0.091 CID_154699691 | ||
| 0.368 | 0.052 | 0.368 | Aldehyde oxidase inhibitor | |||
| 0.322 | 0.008 | 0.322 | Heat shock protein 90 antagonist | 0.121 0.112 CID_154699691 | ||
| 0.322 | 0.022 | 0.462 | DNA methylase inhibitor | 0.462 0.007 CID_154699691 | CID_154699691 | |
| 0.296 | 0.004 | 0.296 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.306 | 0.022 | 0.306 | Mcl-1 antagonist | |||
| 0.286 | 0.007 | 0.286 | Farnesoid X receptor antagonist | 0.122 0.099 CID_154699691 | ||
| 0.295 | 0.019 | 0.295 | Neurotrophic factor enhancer | 0.277 0.025 CID_154699691 | ||
| 0.37 | 0.099 | 0.541 | 5 Hydroxytryptamine release inhibitor | 0.541 0.021 CID_154699691 | CID_154699691 | |
| 0.333 | 0.062 | 0.333 | Calcium channel activator | |||
| 0.3 | 0.034 | 0.498 | Platelet adhesion inhibitor | 0.498 0.005 CID_154699691 | CID_154699691 | |
| 0.28 | 0.014 | 0.285 | Aldehyde dehydrogenase inhibitor | 0.285 0.013 CID_154699691 | CID_154699691 | |
| 0.313 | 0.049 | 0.545 | Tumour necrosis factor alpha release inhibitor | 0.545 0.01 CID_154699691 | CID_154699691 | |
| 0.315 | 0.051 | 0.362 | DNA damaging | 0.362 0.037 CID_154699691 | CID_154699691 | |
| 0.279 | 0.017 | 0.279 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.265 | 0.004 | 0.265 | HIV-1 integrase inhibitor | 0.116 0.017 CID_154699691 | ||
| 0.267 | 0.007 | 0.267 | Potassium channel (Ca-activated) activator | |||
| 0.257 | 0.005 | 0.257 | Histone deacetylase SIRT1 stimulant | 0.218 0.005 CID_154699691 | ||
| 0.257 | 0.005 | 0.257 | Histone deacetylase stimulant | 0.218 0.005 CID_154699691 | ||
| 0.269 | 0.023 | 0.269 | Cyclooxygenase inhibitor | 0.164 0.06 CID_154699691 | ||
| 0.261 | 0.016 | 0.261 | Cholesterol synthesis inhibitor | 0.165 0.038 CID_154699691 | ||
| 0.265 | 0.02 | 0.439 | Alpha-N-acetylglucosaminidase inhibitor | 0.439 0.007 CID_154699691 | CID_154699691 | |
| 0.283 | 0.042 | 0.283 | Sigma receptor agonist | |||
| 0.274 | 0.035 | 0.274 | Neuropeptide Y2 antagonist | |||
| 0.271 | 0.038 | 0.563 | Hepatoprotectant | 0.563 0.005 CID_154699691 | CID_154699691 | |
| 0.24 | 0.008 | 0.24 | Falcipain 2 inhibitor | 0.196 0.015 CID_154699691 | ||
| 0.245 | 0.014 | 0.4 | UDP-glucose 4-epimerase inhibitor | 0.4 0.006 CID_154699691 | CID_154699691 | |
| 0.272 | 0.041 | 0.272 | Anesthetic general | 0.239 0.055 CID_154699691 | ||
| 0.239 | 0.009 | 0.239 | Falcipain inhibitor | 0.198 0.015 CID_154699691 | ||
| 0.234 | 0.004 | 0.234 | Ornithine decarboxylase inhibitor | 0.181 0.005 CID_154699691 | ||
| 0.237 | 0.009 | 0.237 | Porphobilinogen synthase inhibitor | |||
| 0.253 | 0.026 | 0.441 | NOS3 expression enhancer | 0.441 0.006 CID_154699691 | CID_154699691 | |
| 0.264 | 0.038 | 0.464 | Non-steroidal antiinflammatory agent | 0.464 0.008 CID_154699691 | CID_154699691 | |
| 0.24 | 0.014 | 0.24 | GABA C receptor agonist | |||
| 0.247 | 0.021 | 0.247 | Acetylcholinesterase inhibitor | |||
| 0.296 | 0.072 | 0.443 | Spasmolytic | 0.443 0.032 CID_154699691 | CID_154699691 | |
| 0.232 | 0.01 | 0.232 | Estrogen antagonist | 0.101 0.096 CID_154699691 | ||
| 0.228 | 0.006 | 0.228 | Keratolytic | |||
| 0.293 | 0.072 | 0.293 | 5 Hydroxytryptamine release stimulant | 0.221 0.105 CID_154699691 | ||
| 0.238 | 0.023 | 0.238 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.218 | 0.004 | 0.218 | Leukotriene D4 antagonist | 0.047 0.01 CID_154699691 | ||
| 0.219 | 0.005 | 0.219 | Leukotriene antagonist | 0.187 0.006 CID_154699691 | ||
| 0.24 | 0.026 | 0.24 | Phospholipase A2 inhibitor | 0.224 0.032 CID_154699691 | ||
| 0.269 | 0.06 | 0.415 | Vasodilator | 0.415 0.02 CID_154699691 | CID_154699691 | |
| 0.213 | 0.004 | 0.213 | Xanthine dehydrogenase inhibitor | 0.107 0.014 CID_154699691 | ||
| 0.22 | 0.012 | 0.22 | Catalase inhibitor | |||
| 0.214 | 0.007 | 0.214 | Beta tubulin antagonist | |||
| 0.243 | 0.038 | 0.243 | Insulin sensitizer | 0.241 0.04 CID_154699691 | ||
| 0.224 | 0.02 | 0.224 | Mannose-6-phosphate isomerase inhibitor | 0.21 0.025 CID_154699691 | ||
| 0.212 | 0.007 | 0.212 | Thioredoxin inhibitor | 0.209 0.008 CID_154699691 | ||
| 0.213 | 0.014 | 0.213 | Carbonic anhydrase III inhibitor | 0.118 0.045 CID_154699691 | ||
| 0.268 | 0.072 | 0.268 | Aryl hydrocarbon receptor agonist | |||
| 0.215 | 0.02 | 0.215 | Arachidonic acid antagonist | 0.143 0.097 CID_154699691 | ||
| 0.263 | 0.07 | 0.36 | Interleukin agonist | 0.36 0.026 CID_154699691 | CID_154699691 | |
| 0.236 | 0.045 | 0.236 | Dual specificity phosphatase 3 inhibitor | |||
| 0.194 | 0.009 | 0.194 | Inducible nitric-oxide synthase inhibitor | |||
| 0.188 | 0.005 | 0.188 | Thioredoxin reductase inhibitor | 0.102 0.027 CID_154699691 | ||
| 0.195 | 0.014 | 0.195 | Androgen antagonist | |||
| 0.195 | 0.016 | 0.195 | Adenylate cyclase stimulant | 0.138 0.084 CID_154699691 | ||
| 0.19 | 0.013 | 0.19 | TRPA1 agonist | 0.119 0.059 CID_154699691 | ||
| 0.2 | 0.024 | 0.2 | Toll-Like receptor 2 antagonist | |||
| 0.189 | 0.015 | 0.204 | Carbonic anhydrase XIII inhibitor | 0.204 0.013 CID_154699691 | CID_154699691 | |
| 0.182 | 0.008 | 0.182 | Aldose reductase inhibitor | 0.171 0.009 CID_154699691 | ||
| 0.188 | 0.015 | 0.188 | Vanilloid 1 agonist | 0.172 0.022 CID_154699691 | ||
| 0.226 | 0.053 | 0.24 | Nitric-oxide synthase stimulant | 0.24 0.04 CID_154699691 | CID_154699691 | |
| 0.248 | 0.077 | 0.248 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.194 | 0.023 | 0.194 | Antibacterial (Helicobacter pylori) | 0.124 0.075 CID_154699691 | ||
| 0.233 | 0.062 | 0.233 | RNA-directed DNA polymerase inhibitor | 0.195 0.107 CID_154699691 | ||
| 0.204 | 0.033 | 0.204 | Neurotensin receptor agonist | |||
| 0.176 | 0.005 | 0.176 | GABA aminotransferase inhibitor | 0.157 0.007 CID_154699691 | ||
| 0.175 | 0.005 | 0.175 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.216 | 0.048 | 0.216 | Dual specificity phosphatase inhibitor | |||
| 0.176 | 0.009 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.171 0.012 CID_154699691 | ||
| 0.175 | 0.008 | 0.175 | Potassium channel large-conductance Ca-activated activator | |||
| 0.179 | 0.012 | 0.179 | Heat shock protein 70 antagonist | 0.179 0.012 CID_154699691 | ||
| 0.211 | 0.046 | 0.211 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.171 | 0.008 | 0.171 | Interleukin 5 antagonist | 0.137 0.015 CID_154699691 | ||
| 0.187 | 0.024 | 0.187 | Butyrylcholinesterase inhibitor | |||
| 0.203 | 0.04 | 0.384 | Protein kinase stimulant | 0.384 0.009 CID_154699691 | CID_154699691 | |
| 0.174 | 0.012 | 0.174 | DOPA decarboxylase inhibitor | |||
| 0.166 | 0.004 | 0.166 | Potassium channel Kv1.3 blocker | |||
| 0.173 | 0.012 | 0.173 | Estrogen receptor beta antagonist | |||
| 0.193 | 0.035 | 0.334 | Topoisomerase II inhibitor | 0.334 0.014 CID_154699691 | CID_154699691 | |
| 0.164 | 0.01 | 0.164 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.242 | 0.088 | 0.242 | Gastrin inhibitor | |||
| 0.176 | 0.023 | 0.176 | Carbonic anhydrase XV inhibitor | |||
| 0.169 | 0.017 | 0.169 | Creatine kinase inhibitor | |||
| 0.17 | 0.02 | 0.259 | Topoisomerase II alpha inhibitor | 0.259 0.009 CID_154699691 | CID_154699691 | |
| 0.213 | 0.062 | 0.213 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.156 | 0.013 | 0.156 | Acetylcholine release stimulant | 0.15 0.016 CID_154699691 | ||
| 0.18 | 0.038 | 0.18 | Cyclooxygenase 2 inhibitor | 0.12 0.079 CID_154699691 | ||
| 0.16 | 0.018 | 0.16 | Histidine decarboxylase inhibitor | |||
| 0.162 | 0.023 | 0.236 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.236 0.011 CID_154699691 | CID_154699691 | |
| 0.144 | 0.007 | 0.144 | Transcription factor AP-1 inhibitor | 0.1 0.013 CID_154699691 | ||
| 0.202 | 0.066 | 0.202 | Histone acetyltransferase inhibitor | |||
| 0.143 | 0.009 | 0.143 | Bile acid receptor antagonist | 0.096 0.058 CID_154699691 | ||
| 0.178 | 0.046 | 0.178 | Toll-Like receptor 9 antagonist | |||
| 0.152 | 0.02 | 0.152 | Carbonic anhydrase VI inhibitor | 0.088 0.048 CID_154699691 | ||
| 0.139 | 0.008 | 0.139 | Purinergic P2X1 antagonist | 0.058 0.046 CID_154699691 | ||
| 0.135 | 0.005 | 0.135 | Aryl hydrocarbon receptor antagonist | |||
| 0.151 | 0.022 | 0.151 | Transcription factor STAT6 inhibitor | |||
| 0.14 | 0.011 | 0.14 | Prostaglandin EP2 antagonist | 0.128 0.013 CID_154699691 | ||
| 0.165 | 0.037 | 0.165 | Cathepsin H inhibitor | |||
| 0.22 | 0.094 | 0.22 | Calpain inhibitor | |||
| 0.252 | 0.126 | 0.252 | Sodium/bile acid cotransporter inhibitor | |||
| 0.14 | 0.015 | 0.14 | Glutamate decarboxylase inhibitor | |||
| 0.147 | 0.023 | 0.192 | Toll-Like receptor 4 antagonist | 0.192 0.007 CID_154699691 | CID_154699691 | |
| 0.208 | 0.089 | 0.421 | Peptidyltransferase inhibitor | 0.421 0.005 CID_154699691 | CID_154699691 | |
| 0.143 | 0.025 | 0.143 | Nitric-oxide synthase inhibitor | |||
| 0.147 | 0.03 | 0.147 | Caspase 3 inhibitor | |||
| 0.128 | 0.01 | 0.128 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.091 0.02 CID_154699691 | ||
| 0.168 | 0.053 | 0.168 | GABA C receptor rho-2 antagonist | |||
| 0.215 | 0.101 | 0.368 | DNA synthesis inhibitor | 0.368 0.027 CID_154699691 | CID_154699691 | |
| 0.145 | 0.031 | 0.349 | Mediator release inhibitor | 0.349 0.005 CID_154699691 | CID_154699691 | |
| 0.165 | 0.051 | 0.165 | Cytokine production inhibitor | |||
| 0.13 | 0.016 | 0.13 | Estrogen receptor alpha antagonist | |||
| 0.141 | 0.027 | 0.188 | Uric acid excretion stimulant | 0.188 0.015 CID_154699691 | CID_154699691 | |
| 0.125 | 0.011 | 0.125 | D-Ala-D-Ala ligase inhibitor | |||
| 0.164 | 0.051 | 0.171 | Alkaline phosphatase inhibitor | 0.171 0.047 CID_154699691 | CID_154699691 | |
| 0.15 | 0.038 | 0.15 | Ferrochelatase inhibitor | |||
| 0.116 | 0.004 | 0.116 | Catechol O-methyltransferase inhibitor | |||
| 0.116 | 0.004 | 0.116 | Transcription factor RelA inhibitor | |||
| 0.115 | 0.003 | 0.115 | Leukotriene C antagonist | 0.063 0.023 CID_154699691 | ||
| 0.116 | 0.005 | 0.116 | Heme oxygenase stimulant | 0.074 0.021 CID_154699691 | ||
| 0.118 | 0.007 | 0.118 | Histone deacetylase 7 inhibitor | |||
| 0.133 | 0.022 | 0.206 | Phosphofructokinase-1 inhibitor | 0.206 0.01 CID_154699691 | CID_154699691 | |
| 0.129 | 0.018 | 0.129 | Glutathione S-transferase inhibitor | |||
| 0.136 | 0.026 | 0.136 | Alcohol dehydrogenase inhibitor | 0.133 0.027 CID_154699691 | ||
| 0.148 | 0.038 | 0.22 | Microtubule formation inhibitor | 0.22 0.016 CID_154699691 | CID_154699691 | |
| 0.113 | 0.004 | 0.113 | Factor III inhibitor | 0.099 0.005 CID_154699691 | ||
| 0.134 | 0.026 | 0.27 | Triose-phosphate isomerase inhibitor | 0.27 0.006 CID_154699691 | CID_154699691 | |
| 0.116 | 0.008 | 0.176 | Leukotriene B4 antagonist | 0.176 0.004 CID_154699691 | CID_154699691 | |
| 0.122 | 0.014 | 0.122 | Alcohol oxidase inhibitor | |||
| 0.133 | 0.029 | 0.133 | Anabolic | |||
| 0.117 | 0.014 | 0.117 | Estrogen agonist | 0.072 0.026 CID_154699691 | ||
| 0.132 | 0.031 | 0.132 | Prolactin inhibitor | |||
| 0.113 | 0.012 | 0.113 | Maillard reaction inhibitor | |||
| 0.155 | 0.058 | 0.155 | Histone deacetylase SIRT1 inhibitor | |||
| 0.102 | 0.005 | 0.13 | Glucose-6-phosphate translocase inhibitor | 0.13 0.004 CID_154699691 | CID_154699691 | |
| 0.137 | 0.041 | 0.138 | Mucolytic | 0.138 0.04 CID_154699691 | CID_154699691 | |
| 0.121 | 0.028 | 0.219 | NADH dehydrogenase inhibitor | 0.219 0.009 CID_154699691 | CID_154699691 | |
| 0.134 | 0.042 | 0.426 | Expectorant | 0.426 0.004 CID_154699691 | CID_154699691 | |
| 0.231 | 0.141 | 0.422 | Interleukin 2 agonist | 0.422 0.021 CID_154699691 | CID_154699691 | |
| 0.16 | 0.069 | 0.16 | Cholinergic | |||
| 0.104 | 0.014 | 0.104 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.191 | 0.101 | 0.367 | Hypolipemic | 0.367 0.031 CID_154699691 | CID_154699691 | |
| 0.096 | 0.007 | 0.096 | Histone deacetylase 9 inhibitor | |||
| 0.111 | 0.023 | 0.111 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.116 | 0.027 | 0.116 | Macrophage migration inhibitory factor inhibitor | |||
| 0.127 | 0.039 | 0.127 | Urease inhibitor | |||
| 0.103 | 0.015 | 0.149 | Neuraminidase (influenza) inhibitor | 0.149 0.008 CID_154699691 | CID_154699691 | |
| 0.135 | 0.049 | 0.135 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.105 | 0.019 | 0.105 | Estrogen-related receptor beta agonist | |||
| 0.126 | 0.039 | 0.126 | Adenylate kinase inhibitor | 0.102 0.064 CID_154699691 | ||
| 0.165 | 0.078 | 0.295 | ATPase inhibitor | 0.295 0.006 CID_154699691 | CID_154699691 | |
| 0.299 | 0.214 | 0.299 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.154 | 0.069 | 0.154 | CF transmembrane conductance regulator agonist | |||
| 0.109 | 0.024 | 0.109 | Carbonic anhydrase V inhibitor | |||
| 0.088 | 0.003 | 0.088 | Leukotriene C4 antagonist | 0.042 0.02 CID_154699691 | ||
| 0.13 | 0.047 | 0.169 | Photosensitizer | 0.169 0.022 CID_154699691 | CID_154699691 | |
| 0.105 | 0.023 | 0.105 | Carbonic anhydrase VA inhibitor | |||
| 0.086 | 0.005 | 0.086 | Sirtuin 2 inhibitor | |||
| 0.107 | 0.027 | 0.107 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.124 | 0.045 | 0.314 | AMP-activated protein kinase stimulant | 0.314 0.005 CID_154699691 | CID_154699691 | |
| 0.134 | 0.056 | 0.134 | Adenylate cyclase inhibitor | |||
| 0.087 | 0.011 | 0.087 | Histone deacetylase 5 inhibitor | |||
| 0.125 | 0.048 | 0.125 | GABA C receptor antagonist | |||
| 0.101 | 0.026 | 0.101 | Leukotriene synthesis inhibitor | |||
| 0.088 | 0.013 | 0.088 | Estrogen receptor beta agonist | |||
| 0.105 | 0.031 | 0.268 | Cell adhesion molecule inhibitor | 0.268 0.005 CID_154699691 | CID_154699691 | |
| 0.118 | 0.044 | 0.118 | Gastric antisecretory | |||
| 0.093 | 0.021 | 0.093 | Histone deacetylase inhibitor | |||
| 0.086 | 0.014 | 0.086 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.154 | 0.083 | 0.204 | Interleukin 6 antagonist | 0.204 0.038 CID_154699691 | CID_154699691 | |
| 0.083 | 0.013 | 0.083 | Aconitate hydratase inhibitor | |||
| 0.098 | 0.029 | 0.098 | Peroxisome proliferator-activated receptor gamma agonist | 0.072 0.047 CID_154699691 | ||
| 0.077 | 0.009 | 0.077 | Adenylate cyclase 1 inhibitor | |||
| 0.078 | 0.01 | 0.078 | Histone deacetylase 8 inhibitor | |||
| 0.074 | 0.008 | 0.074 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.087 | 0.021 | 0.125 | Neuraminidase inhibitor | 0.125 0.009 CID_154699691 | CID_154699691 | |
| 0.158 | 0.093 | 0.158 | Amyloid beta precursor protein antagonist | |||
| 0.126 | 0.061 | 0.126 | Proteasome inhibitor | |||
| 0.219 | 0.155 | 0.653 | Antithrombotic | 0.653 0.011 CID_154699691 | CID_154699691 | |
| 0.088 | 0.024 | 0.088 | Aromatase inhibitor | |||
| 0.091 | 0.028 | 0.091 | Sirtuin 1 inhibitor | |||
| 0.09 | 0.028 | 0.09 | Glycine receptor agonist | 0.079 0.04 CID_154699691 | ||
| 0.253 | 0.19 | 0.253 | DNA polymerase beta inhibitor | |||
| 0.075 | 0.013 | 0.075 | Estrogen receptor alpha agonist | |||
| 0.095 | 0.033 | 0.095 | Glutamate dehydrogenase inhibitor | 0.066 0.063 CID_154699691 | ||
| 0.089 | 0.027 | 0.089 | MAP kinase kinase 7 inhibitor | |||
| 0.066 | 0.005 | 0.066 | Kainate receptor agonist | |||
| 0.122 | 0.063 | 0.396 | Cell adhesion inhibitor | 0.396 0.005 CID_154699691 | CID_154699691 | |
| 0.107 | 0.048 | 0.107 | Electrolyte absorption antagonist | |||
| 0.073 | 0.015 | 0.073 | Dihydroorotate oxidase inhibitor | |||
| 0.144 | 0.086 | 0.227 | Hexokinase inhibitor | 0.227 0.023 CID_154699691 | CID_154699691 | |
| 0.097 | 0.039 | 0.097 | Myeloperoxidase inhibitor | |||
| 0.083 | 0.025 | 0.083 | Biliverdin reductase inhibitor | 0.053 0.049 CID_154699691 | ||
| 0.109 | 0.051 | 0.109 | GABA C receptor rho-1 antagonist | |||
| 0.108 | 0.051 | 0.108 | Sphingomyelinase inhibitor | 0.092 0.07 CID_154699691 | ||
| 0.064 | 0.008 | 0.064 | Retinoic acid alpha receptor agonist | 0.037 0.031 CID_154699691 | ||
| 0.064 | 0.008 | 0.07 | Guanylate cyclase inhibitor | 0.07 0.005 CID_154699691 | CID_154699691 | |
| 0.064 | 0.01 | 0.064 | Dopamine D5 agonist | |||
| 0.075 | 0.022 | 0.075 | Alpha tubulin antagonist | |||
| 0.073 | 0.021 | 0.073 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.127 | 0.075 | 0.127 | Toll-Like receptor antagonist | |||
| 0.067 | 0.016 | 0.067 | Squalene epoxidase inhibitor | |||
| 0.136 | 0.086 | 0.136 | Thiol protease inhibitor | |||
| 0.076 | 0.026 | 0.076 | Prostaglandin F2 alpha antagonist | |||
| 0.062 | 0.012 | 0.062 | Histone deacetylase class IIa inhibitor | |||
| 0.065 | 0.015 | 0.096 | Glucose-6-phosphate isomerase inhibitor | 0.096 0.005 CID_154699691 | CID_154699691 | |
| 0.055 | 0.005 | 0.055 | Leukotriene B4 receptor 1 antagonist | 0.039 0.012 CID_154699691 | ||
| 0.119 | 0.069 | 0.178 | DNA polymerase I inhibitor | 0.178 0.036 CID_154699691 | CID_154699691 | |
| 0.075 | 0.025 | 0.075 | Carbonic anhydrase VB inhibitor | |||
| 0.173 | 0.123 | 0.422 | Platelet antagonist | 0.422 0.023 CID_154699691 | CID_154699691 | |
| 0.09 | 0.041 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.118 0.018 CID_154699691 | CID_154699691 | |
| 0.075 | 0.027 | 0.075 | MDM2 inhibitor | |||
| 0.09 | 0.043 | 0.122 | Glycine receptor antagonist | 0.122 0.017 CID_154699691 | CID_154699691 | |
| 0.119 | 0.073 | 0.198 | DNA repair enzyme inhibitor | 0.198 0.009 CID_154699691 | CID_154699691 | |
| 0.056 | 0.012 | 0.056 | GABA uptake inhibitor | |||
| 0.051 | 0.007 | 0.051 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.082 | 0.038 | 0.082 | GABA B receptor agonist | |||
| 0.063 | 0.019 | 0.211 | Heparanase inhibitor | 0.211 0.002 CID_154699691 | CID_154699691 | |
| 0.062 | 0.019 | 0.062 | CD45 antagonist | |||
| 0.075 | 0.033 | 0.075 | CDC25B inhibitor | |||
| 0.127 | 0.085 | 0.127 | Neurotrophic factor | |||
| 0.07 | 0.028 | 0.07 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.138 | 0.097 | 0.138 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.053 | 0.012 | 0.053 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.054 | 0.013 | 0.054 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.119 | 0.079 | 0.299 | Cyclooxygenase 3 inhibitor | 0.299 0.006 CID_154699691 | CID_154699691 | |
| 0.044 | 0.004 | 0.044 | Retinoic acid alpha receptor antagonist | |||
| 0.09 | 0.051 | 0.181 | Transcription factor NF kappa B stimulant | 0.181 0.011 CID_154699691 | CID_154699691 | |
| 0.098 | 0.059 | 0.098 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.051 | 0.012 | 0.051 | Retinoid X receptor antagonist | |||
| 0.063 | 0.025 | 0.063 | Pregnane X receptor antagonist | |||
| 0.066 | 0.029 | 0.066 | Botulinum neurotoxin type A inhibitor | |||
| 0.071 | 0.035 | 0.071 | NMDA receptor glycine site agonist | |||
| 0.096 | 0.061 | 0.134 | Phosphodiesterase 6D inhibitor | 0.134 0.015 CID_154699691 | CID_154699691 | |
| 0.215 | 0.182 | 0.517 | Immunosuppressant | 0.517 0.029 CID_154699691 | CID_154699691 | |
| 0.087 | 0.053 | 0.087 | Vanilloid agonist | |||
| 0.094 | 0.061 | 0.094 | Potassium channel (Voltage-sensitive) activator | |||
| 0.065 | 0.033 | 0.065 | Argininosuccinate synthase inhibitor | |||
| 0.046 | 0.013 | 0.046 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.05 | 0.018 | 0.05 | Retinoid X receptor agonist | |||
| 0.069 | 0.037 | 0.069 | NMDA receptor agonist | |||
| 0.036 | 0.005 | 0.036 | Retinoic acid receptor antagonist | 0.02 0.011 CID_154699691 | ||
| 0.233 | 0.202 | 0.233 | DNA directed DNA polymerase inhibitor | |||
| 0.107 | 0.077 | 0.107 | Anesthetic local | |||
| 0.162 | 0.132 | 0.344 | Cyclic AMP phosphodiesterase inhibitor | 0.344 0.027 CID_154699691 | CID_154699691 | |
| 0.037 | 0.008 | 0.037 | Retinoic acid receptor agonist | 0.022 0.018 CID_154699691 | ||
| 0.066 | 0.037 | 0.066 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.042 | 0.013 | 0.042 | Retinoid X alpha receptor antagonist | |||
| 0.039 | 0.011 | 0.039 | Glutamate (mGluR3) agonist | |||
| 0.045 | 0.016 | 0.045 | Retinoid X alpha receptor agonist | |||
| 0.033 | 0.005 | 0.033 | Retinoic acid gamma receptor agonist | |||
| 0.034 | 0.007 | 0.034 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.055 | 0.028 | 0.087 | Carbonic anhydrase XIV inhibitor | 0.087 0.015 CID_154699691 | CID_154699691 | |
| 0.033 | 0.007 | 0.034 | Leukotriene B4 receptor 2 antagonist | 0.034 0.007 CID_154699691 | CID_154699691 | |
| 0.044 | 0.017 | 0.044 | Glutamate (mGluR8) agonist | |||
| 0.075 | 0.049 | 0.075 | CDC25A inhibitor | |||
| 0.069 | 0.045 | 0.069 | Exportin-1 inhibitor | |||
| 0.059 | 0.034 | 0.059 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.072 | 0.048 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.073 | 0.05 | 0.073 | Aminopeptidase I inhibitor | |||
| 0.24 | 0.217 | 0.24 | Calcium channel L-type activator | |||
| 0.04 | 0.017 | 0.04 | Histone deacetylase 4 inhibitor | |||
| 0.036 | 0.014 | 0.036 | Histone deacetylase class II inhibitor | |||
| 0.088 | 0.067 | 0.088 | Glutamate release inhibitor | 0.087 0.069 CID_154699691 | ||
| 0.083 | 0.062 | 0.083 | NMDA receptor antagonist | |||
| 0.042 | 0.021 | 0.042 | Factor XIIIa inhibitor | |||
| 0.032 | 0.012 | 0.032 | Estrogen-related receptor gamma antagonist | |||
| 0.095 | 0.075 | 0.095 | Falcipain 3 inhibitor | |||
| 0.072 | 0.052 | 0.072 | Lipase inhibitor | |||
| 0.029 | 0.009 | 0.029 | Prostaglandin F2 alpha agonist | |||
| 0.091 | 0.072 | 0.091 | Aminopeptidase B inhibitor | |||
| 0.103 | 0.085 | 0.222 | Alkylator | 0.222 0.021 CID_154699691 | CID_154699691 | |
| 0.072 | 0.054 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.021 | 0.004 | 0.021 | Retinoic acid beta receptor antagonist | |||
| 0.036 | 0.021 | 0.036 | Histone deacetylase 2 inhibitor | |||
| 0.056 | 0.04 | 0.066 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.066 0.029 CID_154699691 | CID_154699691 | |
| 0.037 | 0.021 | 0.037 | Fumarate hydratase inhibitor | |||
| 0.024 | 0.009 | 0.024 | Retinoid X beta receptor antagonist | |||
| 0.048 | 0.034 | 0.048 | Dopamine beta hydroxylase inhibitor | |||
| 0.05 | 0.036 | 0.05 | Prolyl endopeptidase inhibitor | |||
| 0.018 | 0.004 | 0.018 | Retinoic acid receptor gamma antagonist | 0.011 0.009 CID_154699691 | ||
| 0.125 | 0.112 | 0.125 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.04 | 0.027 | 0.04 | Histone deacetylase class I inhibitor | |||
| 0.024 | 0.013 | 0.024 | ICAM 1 antagonist | |||
| 0.029 | 0.017 | 0.029 | NMDA 2D receptor antagonist | |||
| 0.083 | 0.071 | 0.083 | Potassium channel activator | |||
| 0.047 | 0.036 | 0.047 | Plasminogen activator inhibitor antagonist | |||
| 0.064 | 0.053 | 0.064 | Glutamate (mGluR6) antagonist | |||
| 0.036 | 0.027 | 0.036 | 5-Alpha-reductase inhibitor | |||
| 0.027 | 0.017 | 0.027 | Nicotinic acid receptor 2 antagonist | |||
| 0.044 | 0.036 | 0.044 | Carbonic anhydrase VII inhibitor | |||
| 0.037 | 0.029 | 0.037 | Potassium channel Kv1.1 blocker | |||
| 0.02 | 0.012 | 0.032 | Antibiotic Anthracycline-like | 0.032 0.003 CID_154699691 | CID_154699691 | |
| 0.063 | 0.056 | 0.063 | Glutamate (mGluR7) antagonist | |||
| 0.031 | 0.024 | 0.031 | ATP citrate lysase inhibitor | |||
| 0.056 | 0.049 | 0.056 | Ryanodine receptor antagonist | |||
| 0.026 | 0.019 | 0.114 | Sodium/glucose cotransporter 2 inhibitor | 0.114 0.002 CID_154699691 | CID_154699691 | |
| 0.041 | 0.035 | 0.041 | Heme oxygenase inhibitor | |||
| 0.033 | 0.026 | 0.033 | RNA-directed RNA polymerase inhibitor | |||
| 0.139 | 0.134 | 0.139 | Catenin beta inhibitor | |||
| 0.051 | 0.046 | 0.051 | Thromboxane synthase inhibitor | |||
| 0.057 | 0.053 | 0.084 | Nitric oxide donor | 0.084 0.019 CID_154699691 | CID_154699691 | |
| 0.024 | 0.021 | 0.105 | Sodium/glucose cotransporter inhibitor | 0.105 0.003 CID_154699691 | CID_154699691 | |
| 0.041 | 0.037 | 0.041 | Glycine transporter 2 inhibitor | |||
| 0.057 | 0.054 | 0.057 | Dopamine D1 antagonist | |||
| 0.059 | 0.056 | 0.059 | Beta 2 adrenoreceptor agonist | |||
| 0.077 | 0.075 | 0.077 | CC chemokine 5 receptor agonist | |||
| 0.027 | 0.025 | 0.027 | Histone deacetylase 11 inhibitor | |||
| 0.027 | 0.025 | 0.027 | Histone deacetylase class IV inhibitor | |||
| 0.085 | 0.084 | 0.25 | Topoisomerase I inhibitor | 0.25 0.017 CID_154699691 | CID_154699691 | |
| 0.017 | 0.016 | 0.017 | Estrogen-related receptor gamma agonist | |||
| 0.038 | 0.036 | 0.038 | Plasmepsin II inhibitor | |||
| 0.048 | 0.047 | 0.093 | Alpha-mannosidase inhibitor | 0.093 0.008 CID_154699691 | CID_154699691 | |
| 0.027 | 0.026 | 0.027 | Prostaglandin agonist | |||
| 0.032 | 0.031 | 0.032 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.031 | 0.03 | 0.031 | Glutamate (mGluR4) agonist | |||
| 0.054 | 0.053 | 0.054 | TRPA1 antagonist | |||
| 0.036 | 0.035 | 0.036 | Vanilloid 3 antagonist | |||
| 0.065 | 0.069 | 0.241 | Antineoplastic antibiotic | 0.241 0.015 CID_154699691 | CID_154699691 | |
| 0.15 | 0.155 | 0.467 | Immunostimulant | 0.467 0.034 CID_154699691 | CID_154699691 | |
| 0.022 | 0.027 | 0.036 | Vanilloid 2 agonist | 0.036 0.005 CID_154699691 | CID_154699691 | |
| 0.021 | 0.027 | 0.024 | Uridine phosphorylase inhibitor | 0.024 0.023 CID_154699691 | CID_154699691 | |
| 0.014 | 0.022 | 0.02 | Telomerase stimulant | 0.02 0.008 CID_154699691 | CID_154699691 | |
| 0.049 | 0.06 | 0.07 | Adenine nucleotide translocase inhibitor | 0.07 0.015 CID_154699691 | CID_154699691 | |
| 0.036 | 0.048 | 0.093 | Mannosidase inhibitor | 0.093 0.006 CID_154699691 | CID_154699691 | |
| 0.076 | 0.09 | 0.129 | ATPase (Vacuolar H+) inhibitor | 0.129 0.015 CID_154699691 | CID_154699691 | |
| 0.051 | 0.066 | 0.071 | Lipocortins synthesis agonist | 0.071 0.02 CID_154699691 | CID_154699691 | |
| 0.106 | 0.123 | 0.261 | Cell wall synthesis inhibitor | 0.261 0.014 CID_154699691 | CID_154699691 | |
| 0.007 | 0.024 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.007 CID_154699691 | CID_154699691 | |
| 0.04 | 0.059 | 0.117 | Factor IXa inhibitor | 0.117 0.006 CID_154699691 | CID_154699691 | |
| 0.026 | 0.064 | 0.075 | Phosphorylase inhibitor | 0.075 0.018 CID_154699691 | CID_154699691 | |
| 0.03 | 0.074 | 0.054 | Microtubule stabilization | 0.054 0.023 CID_154699691 | CID_154699691 | |
| 0.098 | 0.142 | 0.184 | Diuretic | 0.184 0.051 CID_154699691 | CID_154699691 | |
| 0.011 | 0.055 | 0.02 | Corticosteroid-like | 0.02 0.016 CID_154699691 | CID_154699691 | |
| 0.03 | 0.076 | 0.061 | Neuraminidase (Influenza A) inhibitor | 0.061 0.012 CID_154699691 | CID_154699691 | |
| 0.165 | 0.216 | 0.264 | Angiogenesis inhibitor | 0.264 0.113 CID_154699691 | CID_154699691 | |
| 0.009 | 0.083 | 0.039 | Arginase inhibitor | 0.039 0.023 CID_154699691 | CID_154699691 | |
| 0.007 | 0.119 | 0.044 | Squalene synthetase inhibitor | 0.044 0.016 CID_154699691 | CID_154699691 | |
| 0.103 | 0.249 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.035 CID_154699691 | CID_154699691 | |
| 0.021 | 0.169 | 0.382 | Selectin antagonist | 0.382 0.004 CID_154699691 | CID_154699691 | |
| 0.002 | 0.152 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 CID_154699691 | CID_154699691 | |
| 0.06 | 0.211 | 0.105 | Interleukin 12 antagonist | 0.105 0.047 CID_154699691 | CID_154699691 | |
| 0.009 | 0.181 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 CID_154699691 | CID_154699691 | |
| 0.009 | 0.188 | 0.058 | Protein 30S ribosomal subunit inhibitor | 0.058 0.006 CID_154699691 | CID_154699691 | |
| 0.017 | 0.216 | 0.111 | Protein 50S ribosomal subunit inhibitor | 0.111 0.011 CID_154699691 | CID_154699691 | |
| 0.017 | 0.229 | 0.081 | Antibiotic Aminoglycoside-like | 0.081 0.004 CID_154699691 | CID_154699691 | |
| 0.065 | 0.33 | 0.302 | Hemostatic | 0.302 0.015 CID_154699691 | CID_154699691 | |
| 0.036 | 0.306 | 0.316 | Thrombolytic | 0.316 0.021 CID_154699691 | CID_154699691 | |
| 0.129 | 0.403 | 0.785 | Cyclophilin D inhibitor | 0.785 0.008 CID_154699691 | CID_154699691 | |
| 0.024 | 0.351 | 0.097 | DNA intercalator | 0.097 0.077 CID_154699691 | CID_154699691 | |
| 0.009 | 0.625 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.01 CID_154699691 | CID_154699691 | |
| 0.036 | 0.667 | 0.381 | Immunomodulator | 0.381 0.05 CID_154699691 | CID_154699691 | |
| 0.018 | 0.664 | 0.219 | Insulin secretagoues | 0.219 0.028 CID_154699691 | CID_154699691 | |
| 0.01 | 0.684 | 0.209 | Anticoagulant | 0.209 0.05 CID_154699691 | CID_154699691 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |